|Articles|April 13, 2003
ASCRS scientific program committee highlights symposium papers
San Francisco-If the more than 1,000 abstracts submitted to the annualmeeting of the American Society of Cataract and Refractive Surgery (ASCRS)are any indication, this year's symposium papers are representative of thelatest ophthalmic trends.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
5











































.png)


